Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Fire Galbraith

<< Previous

Bullboard Posts

Next >>

Post by DryBoneson Nov 01, 2020 12:49pm

171 Views

Post# 31820229

Fire Galbraith

and every board memeber. Then set the company right. Claw back their pension plans,
salaries, options, warrents, Send them a bill for use of the company call, and travel cost
to go on road to spread fake news about the company.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023